UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 6)*

MedAire, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share
(Title of Class of Securities)

U58215101
(CUSIP Number)

Leonardo Loo, Esq.
Fennemore Craig, P.C.
3003 North Central Avenue
Suite 2600
Phoenix, Arizona 85012-2913
(602) 916-5000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

September 14, 2007
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box o.

Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent.


*		The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SEC 1746 (12-91)

SCHEDULE 13D


CUSIP NO. U58215101				Page 2 of 12 Pages

SEC 1746 (12-91)


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Excellus Investments Pte Ltd.


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	Republic of Singapore

		7	SOLE VOTING POWER

NUMBER OF			860,000

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			860,000

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	CO


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 3 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Best Dynamic Services Limited


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	British Virgin Islands

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	CO


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 4 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Blue Cross Travel Services B.V.


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	The Netherlands

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	CO


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 5 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON International SOS (EMEA) Holdings N.V.


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	Netherlands Antilles

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	CO


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 6 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON AEA International Holdings Limited


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	WC

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	British Virgin Islands

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	CO


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 7 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Arnaud P.A. Vaissie


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	France

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	IN


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 8 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Pascal M.G. Rey-Herme


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	France

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	IN


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

SCHEDULE 13D


CUSIP NO. U58215101				Page 9 of 12 Pages


1	NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Laurent Sabourin


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o
	(b) þ

3	SEC USE ONLY



4	SOURCE OF FUNDS*

	AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	France

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			50,500,369 (1)

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH		10	SHARED DISPOSITIVE POWER

			50,500,369 (1)

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	50,500,369 (1)

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	87.52% (1)

14	TYPE OF REPORTING PERSON*

	IN


(1)		The Reporting Person disclaims beneficial interest in 15,226,065 shares of common stock of MedAire, Inc. held through Procuro, Inc., a Nevada corporation, of which may be deemed to be beneficially owned by Joan Sullivan Garrett and/or Gaelic, L.L.C., formerly known as Connemara, L.L.C. The 15,226,065 shares represent approximately 26.39% of the issued and outstanding common stock of MedAire, Inc. See also Items 4 and 5 below.

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION

TABLE OF CONTENTS


	Item 1. Security and Issuer
	Item 2. Identity and Background
	Item 3. Source and Amount of Funds or Other Consideration
	Item 4. Purpose of Transaction
	Item 5. Interest in Securities of the Issuer
	Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
	Item 7. Material to Be Filed as Exhibits
SIGNATURES
EX-1

SCHEDULE 13D


CUSIP NO. U58215101				Page 10 of 12 Pages

Item 1. Security and Issuer

This Amendment No. 6, filed by Excellus Investments Pte Ltd., a corporation organized under the laws of the Republic of Singapore (“Excellus”), Best Dynamic Services Limited, a corporation organized under the laws of the British Virgin Islands (“BDS,” and together with Excellus, the “BDS Parties”), Blue Cross Travel Services B.V., a corporation organized under the laws of The Netherlands (“Blue Cross”), International SOS (EMEA) Holdings N.V., a corporation organized under the laws of Netherlands Antilles (“ISOSH”), AEA International Holdings Limited, a corporation organized under the laws of the British Virgin Islands (“AEA Holdings”), Arnaud P.A. Vaissie (“Vaissie”), Pascal M.G. Rey-Herme (“Rey-Herme”), and Laurent Sabourin (“Sabourin”, together with Vaissie, Rey-Herme, Excellus, BDS, Blue Cross, ISOSH, and AEA Holdings, the “Reporting Persons” and each a “Reporting Person”), amends and supplements the Schedule 13D (“Schedule 13D”) filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on November 29, 2006, and amended on March 16, 2007, April 23, 2007, June 6, 2007, June 29, 2007, and August 31, 2007, relating to the common stock, $0.001 par value (the “Common Stock” or “Shares”), of MedAire, Inc., a Nevada corporation (the “Issuer”).

Item 2. Identity and Background

No change.

Item 3. Source and Amount of Funds or Other Consideration

Item 3 is hereby amended to add the following:

On September 14, 2007, Excellus transferred 1,400,000 shares of Common Stock of the Issuer into Procuro as a capital contribution in exchange for shares of Procuro common stock, $0.001 par value per share, pursuant to the terms of the Shareholders Agreement. On September 19, 2007, Excellus purchased an additional 10,000 shares of Common Stock for an aggregate purchase price of $10,737.50. The shares were purchased with working capital contributed to Excellus by AEA Holdings out of its working capital.

Item 4. Purpose of Transaction

No change.

Item 5. Interest in Securities of the Issuer

Item 5 is hereby amended and restated in its entirety to read as follows:

The descriptions contained in Item 3 and Item 4 above are incorporated herein by reference. Based on the Issuer’s Form 10-Q filed on August 14, 2007, as of June 30, 2007, there were outstanding 57,702,337 shares of Common Stock of the Issuer. As of the date hereof, the Reporting Persons are deemed to beneficially own, and hold share voting and dispositive power over, 35,274,304 shares of Common Stock of the Issuer, representing approximately 61.13% of the issued and outstanding Common Stock of the Issuer, 14,780,149 of which are beneficially owned by BDS indirectly through Procuro, 19,634,155 of which are beneficially owned by Excellus indirectly through Procuro, and 860,000 of which are currently owned directly by Excellus but which will be contributed to Procuro. Additionally, because of the transactions described in Item 4, the Reporting Persons may be deemed to own or share the power to vote the shares of Common Stock beneficially owned by Gaelic and/or Garrett. The Reporting Persons expressly disclaim such beneficial ownership and expressly disclaim that they are members of any group for purposes of Section 13(d) or 13(g) of the Act, and that they have agreed to act as a group other than as described in this Schedule 13D. To the Reporting Persons’ knowledge, Gaelic and Garrett are the beneficial owners of 15,236,465 shares of Common Stock of the Issuer, representing approximately 26.41% of the issued and outstanding Common Stock of the Issuer, 15,226,065 of which are beneficially owned by Gaelic through Procuro and 10,400 of which are currently owned directly by Garrett but which will be contributed to Procuro.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

No change.

SCHEDULE 13D


CUSIP NO. U58215101				Page 11 of 12 Pages

Item 7. Material to Be Filed as Exhibits

Exhibit 1 – Joint Filing Agreement of the Reporting Persons.

SCHEDULE 13D


CUSIP NO. U58215101				Page 12 of 12 Pages

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Date: September 24, 2007	EXCELLUS INVESTMENTS PTE LTD.

	By:	/s/ Laurent Sabourin

	Name: Laurent Sabourin
	Title: Director

	BEST DYNAMIC SERVICES LIMITED

	By:	/s/ Laurent Sabourin

	Name: Laurent Sabourin
	Title: Director

	BLUE CROSS TRAVEL SERVICES B.V.

	By:	/s/ Laurent Sabourin

	Name: Laurent Sabourin
	Title: Managing Director

	INTERNATIONAL SOS (EMEA) HOLDINGS N.V.

	By:	/s/ Laurent Sabourin

	Name: Laurent Sabourin
	Title: Managing Director

	AEA INTERNATIONAL HOLDINGS LIMITED

	By:	/s/ Laurent Sabourin

	Name: Laurent Sabourin
	Title: Director

	ARNAUD P.A. VAISSIE

	/s/ Arnaud P.A. Vaissie


	PASCAL M.G. REY-HERME

	/s/ Pascal M.G. Rey-Herme


	LAURENT SABOURIN

	/s/ Laurent Sabourin

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

MedAire, Inc. SC 13D/A